Bi-directional signaling between melanoma and the microenvironment generates a protective niche that mediates therapeutic escape
Very few cancer patients are cured through drug therapy alone, with the majority exhibiting acquired resistance. To date, most studies of therapeutic escape have focused upon tumor-intrinsic mechanisms of drug resistance with little attention paid to the role of normal host cells in preventing compl...
Main Author: | Fedorenko, Inna |
---|---|
Format: | Others |
Published: |
Scholar Commons
2014
|
Subjects: | |
Online Access: | https://scholarcommons.usf.edu/etd/5215 https://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=6411&context=etd |
Similar Items
-
An integrin-based mechanism for sensitizing melanomas to therapies
by: Sun, Xiaowen
Published: (2015) -
The evolution of combined molecular targeted therapies to advance the therapeutic efficacy in melanoma: a highlight of vemurafenib and cobimetinib
by: Medina TM, et al.
Published: (2016-06-01) -
The role of BRAF V600 mutation in melanoma
by: Ascierto Paolo A, et al.
Published: (2012-07-01) -
The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response
by: Rita Cabrita, et al.
Published: (2020-03-01) -
Role of vemurafenib in the treatment of disseminated skin melanoma
by: L V Demidov, et al.
Published: (2013-06-01)